Call Us : +917923293629
Gemcitabine Injection Ip 200 Mg Gemcitabine Injection Ip 200 Mg Gemcitabine Injection Ip 200 Mg Gemcitabine Injection Ip 200 Mg Gemcitabine Injection Ip 200 Mg Gemcitabine Injection Ip 200 Mg
Gemcitabine Injection Ip 200 Mg
Gemcitabine Injection Ip 200 Mg Gemcitabine Injection Ip 200 Mg Gemcitabine Injection Ip 200 Mg Gemcitabine Injection Ip 200 Mg Gemcitabine Injection Ip 200 Mg

Gemcitabine Injection Ip 200 Mg

Rs 450/ Vial INR

Product Details:

  • Drug Type Drug Solutions
  • Ingredients Gemcitabine 200 mg
  • Physical Form Liquid
  • Function Anti-Cancer
  • Dosage injection
  • Dosage Guidelines As guided by physician
  • Quantity gemcitabine 200 mg Boxes
  • Supply Ability : 10000 Per Month
  • Click to view more
X

Price And Quantity

  • Rs 450/ Vial INR

Product Specifications

  • Room Temperature (25 C Temperature)
  • As guided by physician
  • Drug Solutions
  • gemcitabine 200 mg Boxes
  • Anti-Cancer
  • injection
  • Gemcitabine 200 mg
  • Liquid

Trade Information

  • Delhi, Mumbai
  • Paypal, Western Union, Telegraphic Transfer (T/T), Letter of Credit at Sight (Sight L/C), Letter of Credit (L/C), Cheque, Cash in Advance (CID), Cash Advance (CA)
  • 10000 Per Month
  • 7 Days
  • per Box 1 vial
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
  • All India

Product Description

Qualitative and quantitative composition :
  • One vial contains gemcitabine hydrochloride equivalent to 200 mg gemcitabine.
  • After reconstitution, the solution contains 38 mg/ml of gemcitabine.
  • Excipients
  • Each 200 mg vial contains 3.5 mg (<1 mmol) sodium.
  • Pharmaceutical form
  • Powder for solution for infusion.
  • White to off-white plug or powder.
Clinical particulars :
  • Gemcitabine is indicated for the treatment of locally advanced or metastatic bladder cancer in combination with cisplatin.
  • Gemcitabine is indicated for treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas.
  • Gemcitabine, in combination with cisplatin is indicated as first line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC). Gemcitabine monotherapy can be considered in elderly patients or those with performance status 2.
  • Gemcitabine is indicated for the treatment of patients with locally advanced or metastatic epithelial ovarian carcinoma, in combination with carboplatin, in patients with relapsed disease following a recurrence-free interval of at least 6 months after platinum-based, first-line therapy.
  • Gemcitabine, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated.

HEET HEALTHCARE PVT. LTD.

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.